<DOC>
	<DOCNO>NCT00267280</DOCNO>
	<brief_summary>The Torcetrapib project terminate December 2 , 2006 due safety finding . Cholesterol level measure six week subject treat two different kind cholesterol medication see different treatment compare one another .</brief_summary>
	<brief_title>A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol ( A5091031 ) .</brief_title>
	<detailed_description>For additional information please call : 1-800-718-1021</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Torcetrapib</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>eligible statin treatment LDL cholesterol NCEP guideline Women pregnant lactating , plan become pregnant . Subjects take drug know associate increase risk myositis combination HMGCoA reductase inhibitor . Subjects significant liver kidney disease significant heart failure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>